US2015098932A1PendingUtilityA1
Compositions and methods for treatment of vitiligo
Est. expiryDec 21, 2029(~3.4 yrs left)· nominal 20-yr term from priority
Inventors:Sarah S. Bacus
E01C 23/16A61K 31/133A61P 17/00A61K 38/44A61K 31/355A61K 38/1825A61K 31/436
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compositions and methods are disclosed for treating vitiligo and promoting the formation of collagen.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of treating vitiligo comprising topically administering to an affected area of a subject in need thereof a composition comprising a cosmeceutically acceptable medium and from about 0.1 to about 0.5 weight percent rapamycin to treat the subject.
2 . The method according to claim 1 , wherein the composition further comprises fibroblast growth factor.
3 . The method according to claim 2 , wherein the composition comprises from about 0.000015 to about 0.00005 weight percent fibroblast growth factor.
4 . The method according to claim 1 , wherein the composition further comprises vitamin E.
5 . The method according to claim 4 , wherein the composition comprises about 0.5 weight percent vitamin E.
6 . A method according to claim 1 , wherein the composition further comprises tromethamine.
7 . A method according to claim 6 , wherein the composition comprises about 0.5 weight percent tromethamine.
8 . A method according to claim 1 , wherein the composition further comprises glutathione peroxidase.
9 . A method according to claim 8 , wherein the composition comprises about 0.3 weight percent glutathione peroxidase.
10 . A method according to claim 1 , wherein the composition further comprises catalase.
11 . A method according to claim 10 , wherein the composition comprises about 0.3 weight percent catalase.
12 . A method according to claim 1 , wherein the composition is a leave-on product.
13 . The method according to claim 1 , wherein the composition is administered to the subject at least twice daily.
14 . The method according to claim 1 , wherein about 0.25 mL of the composition is administered to the subject at least twice daily.
15 . The method according to claim 1 , wherein about 0.35 mL of the composition is administered to the subject at least twice daily.
16 . A method of treating vitiligo comprising topically administering to an affected area of a subject in need thereof a composition comprising:
a) a cosmeceutically acceptable medium; b) from about 0.1 to about 0.5 weight percent rapamycin; c) from about 0.000015 to about 0.00005 weight percent fibroblast growth factor; d) from about 0.5 weight percent vitamin E; e) from about 0.5 weight percent tromethamine; f) from about 0.3 weight percent gluthione peroxidase; and g) from about 0.3 weight percent catalase.Join the waitlist — get patent alerts
Track US2015098932A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.